What is Enteric Disease Testing?

Enteric Disease Testing involves diagnostic procedures to identify infections and diseases affecting the intestines, often caused by bacteria, viruses, or parasites. It plays a crucial role in ensuring timely and accurate diagnosis for effective treatment.

How big is the Enteric Disease Testing Market?

The global Enteric Disease Testing Market size was estimated at USD 3.9 Billion in 2023 and is expected to reach USD 5.1 Billion in 2033.

What is the Enteric Disease Testing Market growth?

The global Enteric Disease Testing Market is expected to grow at a compound annual growth rate of 2.8%. From 2024 To 2033

Who are the key companies/players in the Enteric Disease Testing Market?

Some of the key players in the Enteric Disease Testing Markets are Abbott Laboratories, Becton Dickinson & Company, Bio-Rad Laboratories, Inc., Meridian Bioscience Inc., Biomerieux SA, Trinity Biotech, Cepheid, Inc., Quest Diagnostics Incorporated, Biomerica, Coris BioConcept

Why is Enteric Disease Testing Important?

Enteric Disease Testing is vital for early detection of infections in the gastrointestinal tract, facilitating prompt medical intervention. Timely diagnosis helps prevent the spread of diseases, enables targeted treatment, and contributes to better patient outcomes.

What Are Common Methods Used in Enteric Disease Testing?

Common methods include Traditional, Rapid, Convenience-based, Polymerase chain reaction (PCR) and immunoassay technologies. These methods help identify specific pathogens responsible for enteric diseases.

Who Benefits from Enteric Disease Testing?

Healthcare providers, laboratories, and patients benefit from Enteric Disease Testing. Healthcare providers can make informed treatment decisions, laboratories play a key role in conducting tests, and patients receive timely and accurate diagnoses.

Global Enteric Disease Testing Market By Disease Type-Bacterial Enteric Disease, Viral Enteric Disease-(Rotavirus, Norovirus)Parasitic Enteric Disease, By Technology-(Traditional, Rapid, Convenience-based, Polymerase chain reaction (PCR), Immunoassay, Other Technologies) By End User-(Hospitals, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2033

Published date: July 2024
Report ID: 13965
Number of Pages: 202
Format:

- Abbott Laboratories
- Becton Dickinson & Company
- Bio-Rad Laboratories, Inc. Company Profile
- Meridian Bioscience Inc.
- Biomerieux SA
- Trinity Biotech
- Cepheid, Inc.
- Quest Diagnostics Incorporated
- Biomerica
- Coris BioConcept
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 13965
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (32)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)